Methods to identify prime and boost immunogens for use in a B cell lineage-based vaccination protocol

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 10835599
APP PUB NO 20190167783A1
SERIAL NO

16155018

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates, in general, to an HIV-1 vaccine and, in particular, to a B cell lineage-based vaccination protocol.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
DUKE UNIVERSITY2812 ERWIN RD STE 406 DURHAM NC 27705

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Harrison, Stephen Boston, US 111 3089
Haynes, Barton F Durham, US 163 638
Kelsoe, Garnett Durham, US 10 27
Kepler, Thomas B Boston, US 9 37

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 May 17, 2028
11.5 Year Payment $7400.00 $3700.00 $1850.00 May 17, 2032
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00